Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer.

Yuki KochiSatoshi HosoyaNozomu YanaiharaChie NagataRie HondaMiwako ShimazakiKota YokosuTakafumi KurodaMotoaki SaitoHiroshi TanabeKyosuke YamadaHirokuni TakanoAikou Okamoto

Published in: International journal of clinical oncology (2024)

Our study may indicate ddTC, BEV, and their combination regimen as the promising first-line chemotherapy option among Japanese patients with advanced EOC.

Keyphrases

phase ii study
locally advanced
randomized controlled trial
clinical trial
radiation therapy
metastatic colorectal cancer
phase iii
open label
double blind